Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Actually i am sure sure that’s quite right.
I have no doubt Newland tries to pump the price up regularly with zero content announcements. And i have been ultra-negative on him. But if this is what it purports to be it has potential to be quite significant.
But now he’s actually announced three contracts. Small maybe - but signs that there is real commercial interest.
Anyway that was enough for me to put a toe ( no more ) back in the water.
I am sure there will be an equity issue. But if he keeps these coming it will be off a much higher price.
My remaining concern is he has alienated all the Institutional holders - but we will see.
Rolling in, including the one today with Astrazeneca for over half a million £.
Shorters want holders to sell.
Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. Cash call may NOT be needed................
All IMHO.
How thoughtful of astra zeneca to be so obliging
Tend to agree with Dibs and others...
I'd hope for a more decent spike
back to nthe waiting game
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.
The Guildford, England-based liquid biopsy company, which specialises in circulating tumour cell solutions for use in drug development and clinical oncology, has signed a supplier agreement with Cambridge-based AstraZeneca PLC.
Shares in Angle were up 16% at 15.99 pence each in London on Friday afternoon.
Under the terms of the agreement, worth GBP550,000 to Angle, the company will develop an androgen-receptor assay, using its CTC Parsortix technology, for use in prostate cancer studies.
Development will take place in the Angle's UK laboratories, and completion of the project is expected in the first quarter of 2025.
"A successful development phase will demonstrate the importance of the Parsortix system in assessing the efficacy of prostate cancer therapeutics and offers the potential for long-term, ongoing business for the company supporting clinical studies," Angle said.
Chief Executive Officer Andrew Newland said: "This is further validation of Angle's Parsortix system which shows potential for long-term large-scale revenues in bringing innovative new cancer drugs to the market. We anticipate that success in this first phase of assay development may lead to much larger contracts for use of the assay in clinical trials".
By Hugh Cameron, Alliance News reporter
Peeps crying after selling out on the cheap yesterday and this morning. Looks like they will be paying more to buy back.
Looks like seller out. Mms moving this up now.
Typical Newland. A succession of planned RNS releases perfectly timed to and intentional to get SP up. Still way short of where I’m sure they hoped it would be (over 30p +
Seen the pattern so many times before. Whatever thing go deadly quiet after the fundraising.Lol
Up 25% now.
Good luck.
Just cancelled my sell order - MM's been holding this back today - more media over the weekend - short blue week next week.
GLA SR
MMs letting it go! Very strong finish on the cards.
Up 21%. Ticked up again.
Bantham. You only seem to have negative thoughts! The sp is telling us things are picking up BIGTIME. The sp was a tad below 10p last November. It's now 16.75p. More than 50% more. The contracts have only just started to arrive. LOADS to come IMHO.
All IMHO.
So you don’t think they will raise?m The company have told you that even if they make £6.6m this year in revenue they will have zero cash by end Q2. So one thing is certain - they need a lot of cash. If it all comes from customers - great. But no signs of that yet.
Up 20% now.
Just ticked up.
Wow. Don't see that very often!
Bantham. That statement is ridiculous. For example. Angle are looking for a Pharma partner to join them and Bioview to market the HER2 system Bioview and Angle have spent just over a year developing. An up front payment to become that partner could be in the milions. Just one example. We know they talk to Eisai and Astrazeneca already......
You are so quick to look on the bad side!
All IMHO.
EC - not a cat in he11’s chance there’s no raise by Q1 25.
But if he can build some belief ahead of it - then maybe it won’t be sp destructive as i feared……
Better than expected job figures in USA. Dow futures now up 500pts
Landing a half million £ contract with Astrazeneca might be better appreciated by the yanks!
Bantham.
It's 4th May 2024. Angle cash runway WAS until 1st quarter 2025. It is possible a cash raise won't be necessary. Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. It's easily doable now.
All IMHO.
Watch the January presentation available on YouTube. Cash runway till 2025
FEVERTREEMAN. - i have bought some today. I have done this several times and always regretted it given the hype and nonsense from Newland. But maybe we are seeing something here.
But let’s not forget - there is a fundraise at some stage.
So i would urge people not to get too over-excited ( I’ve already seen crazy ramping this morning by people who know zero about this situation )
HZM up 16%,, leaky
After the FIRST Astrazeneca contract on 24th April.....
THIS TIME I THINK 20P PLUS.
USA interest..........
aLL imho!!!
I see you have the serial ramper over here now
PRICK123 ramps and pumps every blue board
🔔end